Patricia Greninger Selected Research

verucopeptin

11/2020

Pharmacological Targeting of Vacuolar H+-ATPase via Subunit V1G Combats Multidrug-Resistant Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia Greninger Research Topics

Disease

31	Neoplasms (Cancer) 01/2022 - 12/2007
9	Lung Neoplasms (Lung Cancer) 01/2018 - 05/2008
5	Neuroblastoma 01/2022 - 05/2008
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 05/2014
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 11/2013
2	Cholangiocarcinoma 01/2022 - 01/2016
2	Hypersensitivity (Allergy) 01/2018 - 01/2016
2	Carcinogenesis 01/2018 - 01/2010
1	Liver Neoplasms (Liver Cancer) 01/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021
1	Melanoma (Melanoma, Malignant) 11/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018
1	Lymphoma (Lymphomas) 01/2018
1	Breast Neoplasms (Breast Cancer) 10/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2016
1	Leukemia 11/2013
1	Fanconi Anemia (Fanconi's Anemia) 10/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2013
1	Oncogene Addiction 03/2012
1	Ewing Sarcoma (Sarcoma, Ewing) 03/2012
1	Colonic Neoplasms (Colon Cancer) 02/2012
1	Chromosomal Instability (Chromosome Stability) 01/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2009
1	Sarcoma (Soft Tissue Sarcoma) 05/2009
1	Rhabdomyosarcoma 05/2009

Drug/Important Bio-Agent (IBA)

7	Phosphotransferases (Kinase)IBA 01/2022 - 12/2007
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2008
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 03/2012
4	venetoclaxIBA 01/2021 - 01/2018
3	Drug CombinationsIBA 01/2023 - 12/2014
3	ErbB Receptors (EGF Receptor)IBA 12/2021 - 10/2013
3	Tyrosine Kinase InhibitorsIBA 01/2018 - 05/2009
2	SHP099IBA 01/2022 - 01/2022
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2018
2	Lysine (L-Lysine)FDA Link 01/2018 - 03/2015
2	ChromatinIBA 03/2015 - 05/2014
2	Anaplastic Lymphoma KinaseIBA 12/2014 - 05/2008
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2013 - 03/2012
2	Cyclin EIBA 11/2012 - 01/2010
1	Alkylating AgentsIBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	EpiregulinIBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Focal Adhesion Protein-Tyrosine KinasesIBA 12/2021
1	Monocarboxylic Acid TransportersIBA 01/2021
1	AZD3965IBA 01/2021
1	S63845IBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	NVP-CGM097IBA 01/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2021
1	Phenformin (Fenformin)IBA 01/2021
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 11/2020
1	verucopeptinIBA 11/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2020
1	Adenosine Triphosphatases (ATPase)IBA 11/2020
1	GSK-J4IBA 01/2018
1	dolichyl-diphosphooligosaccharide - protein glycotransferase (oligosaccharyltransferase)IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	Histone DemethylasesIBA 01/2018
1	DEAD-box RNA HelicasesIBA 01/2018
1	elatolIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	silvestrolIBA 01/2018
1	Histones (Histone)IBA 01/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2018
1	ProteomeIBA 10/2017
1	(+)-JQ1 compoundIBA 01/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2016
1	Dasatinib (BMS 354825)FDA Link 01/2016
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2014
1	Cetuximab (Erbitux)FDA Link 05/2014
1	Glutathione (Reduced Glutathione)IBA 11/2013
1	PlatinumIBA 10/2013
1	olaparibIBA 10/2013
1	Cisplatin (Platino)FDA LinkGeneric 10/2013
1	ABT-737IBA 03/2013
1	Vorinostat FDA Link 03/2013
1	Small Interfering RNA (siRNA)IBA 01/2013
1	cyclopamineIBA 11/2012
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2012
1	RoscovitineIBA 01/2010
1	taxaneIBA 01/2010
1	CyclinsIBA 01/2010
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2010
1	Cyclin D1IBA 01/2010
1	Taxoids (Taxanes)IBA 01/2010
1	LigandsIBA 05/2009
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2009
1	Sunitinib (Sutent)FDA Link 05/2009
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2009

Therapy/Procedure

21	Therapeutics 01/2022 - 05/2009
3	Drug Therapy (Chemotherapy) 12/2021 - 10/2013
1	Immunotherapy 11/2019
1	Chemoprevention 01/2010